Schizandrin attenuates lung lesions induced by Avian pathogenic Escherichia coli in chickens. (May 2020)
- Record Type:
- Journal Article
- Title:
- Schizandrin attenuates lung lesions induced by Avian pathogenic Escherichia coli in chickens. (May 2020)
- Main Title:
- Schizandrin attenuates lung lesions induced by Avian pathogenic Escherichia coli in chickens
- Authors:
- Yuan, Meng
Peng, Lu-Yuan
Wei, Qian
Li, Jing-He
Song, Ke
Chen, Shuang
Huang, Jiang-Ni
Yu, Jia-Lin
An, Qiang
Yi, Peng-Fei
Shen, Hai-Qing
Fu, Ben-Dong - Abstract:
- Abstract: Avian pathogenic Escherichia coli (APEC) can cause serious pathological changes and inflammation in chickens. Schizandrin has anti-inflammatory activity and can prevent damage to various tissues and organs. The purpose of this study was to investigate the protective effect of schizandrin on APEC-induced lung lesions in chickens and explore the potential mechanism of schizandrin protection. The schizandrin (50, 100, and 200 mg/kg) was intragastrically administered for 3 days. APEC was administered using intraperitoneal (i.p.) injection to induce lung lesions. Then, chickens were sacrificed by CO2 inhalation 24 h later and the lung tissues were collected for examining histopathological changes, wet/dry (W/D) ratio, myeloperoxidase (MPO) activity, malondialdehyde (MDA), levels of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and IL-8 and activation of nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways. Our findings showed that schizandrin markedly inhibited pathological changes, pulmonary edema, MPO activity and MDA content. Moreover, schizandrin markedly reduced the levels of TNF-α, IL-1β, IL-6 and IL-8 in lung tissue. Importantly, the mechanism responsible for these effects was attributed to the inhibitory effect of schizandrin on NF-κB and MAPK signaling activation. In conclusion, our findings reveal that schizandrin displays anti-oxidant and anti-inflammatory activity against APEC-induced lung lesions in chickens,Abstract: Avian pathogenic Escherichia coli (APEC) can cause serious pathological changes and inflammation in chickens. Schizandrin has anti-inflammatory activity and can prevent damage to various tissues and organs. The purpose of this study was to investigate the protective effect of schizandrin on APEC-induced lung lesions in chickens and explore the potential mechanism of schizandrin protection. The schizandrin (50, 100, and 200 mg/kg) was intragastrically administered for 3 days. APEC was administered using intraperitoneal (i.p.) injection to induce lung lesions. Then, chickens were sacrificed by CO2 inhalation 24 h later and the lung tissues were collected for examining histopathological changes, wet/dry (W/D) ratio, myeloperoxidase (MPO) activity, malondialdehyde (MDA), levels of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and IL-8 and activation of nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways. Our findings showed that schizandrin markedly inhibited pathological changes, pulmonary edema, MPO activity and MDA content. Moreover, schizandrin markedly reduced the levels of TNF-α, IL-1β, IL-6 and IL-8 in lung tissue. Importantly, the mechanism responsible for these effects was attributed to the inhibitory effect of schizandrin on NF-κB and MAPK signaling activation. In conclusion, our findings reveal that schizandrin displays anti-oxidant and anti-inflammatory activity against APEC-induced lung lesions in chickens, paving the way for rational use of schizandrin as a protective agent against lung-related inflammatory disease. Highlights: The protective effect of schizandrin on APEC-induced lung lesions in chickens was studied. Schizandrin reduced the pathological changes and pulmonary edema of lung tissue induced by APEC-O78. Schizandrin markedly inhibited MPO activity and MDA content in lung tissue. Schizandrin markedly decreased the production of IL-1β, TNF-α, IL-6, and IL-8 in lung tissue. The protective effect of schizandrin on APEC-induced lung lesions was related to NF-κB pathways and MAPK pathways. … (more)
- Is Part Of:
- Microbial pathogenesis. Volume 142(2020)
- Journal:
- Microbial pathogenesis
- Issue:
- Volume 142(2020)
- Issue Display:
- Volume 142, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 142
- Issue:
- 2020
- Issue Sort Value:
- 2020-0142-2020-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-05
- Subjects:
- Schizandrin -- Lung lesion -- Avian pathogenic escherichia coli -- Inflammation
Pathogenic microorganisms -- Periodicals
Pathology, Molecular -- Periodicals
Communicable Diseases -- microbiology -- Periodicals
Communicable Diseases -- parasitology -- Periodicals
Micro-organismes pathogènes -- Périodiques
Pathologie moléculaire -- Périodiques
Electronic journals
616.9041 - Journal URLs:
- http://www.sciencedirect.com/science/journal/08824010 ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0882-4010;screen=info;ECOIP ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.micpath.2020.104059 ↗
- Languages:
- English
- ISSNs:
- 0882-4010
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5756.955000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13452.xml